Nanotechnology and vaccine development
Despite the progress of conventional vaccines, improvements are clearly required due to concerns about the weak immunogenicity of these vaccines, intrinsic instability in vivo, toxicity, and the need for multiple administrations. To overcome such problems, nanotechnology platforms have recently been...
Main Authors: | Mi-Gyeong Kim, Joo Yeon Park, Yuna Shon, Gunwoo Kim, Gayong Shim, Yu-Kyoung Oh |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-10-01
|
Series: | Asian Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S181808761400035X |
Similar Items
-
Editorial: Lipid Nanoparticles as a Novel Strategy to Deliver Bioactive Molecules
by: Alan Talevi, et al.
Published: (2021-03-01) -
An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery
by: Kailash C. Petkar, et al.
Published: (2021-03-01) -
Frontiers in pharmaceutical nanotechnology
by: Matthias G. Wacker
Published: (2019-12-01) -
Production, characterization and toxicology assay of creatine pegylated nanoliposome with polysorbate 80 for brain delivery
by: DIEGO B. BORIN, et al.
Published: (2018-04-01) -
Advances in Nanomaterials in Biomedicine
by: Elena Ryabchikova
Published: (2021-01-01)